StockData
Amneal Pharmaceuticals, Inc. logo

Amneal Pharmaceuticals, Inc. (AMRX) stock

AMRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3062% above fair value
$21.23−0.15 (-0.70%)

Close on Nov 16, 2026Market cap $6.78BP/E 43.3Yield –

Amneal Pharmaceuticals total assets

Total assets on the balance sheet at the end of each period.

Amneal Pharmaceuticals's total assets was $3.78B at Jun 30, 2026. For fiscal 2025 it was $3.68B, up 5.1% from the year before. The highest annual figure on record is $4.35B in fiscal 2018.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.68B+5.1%
FY2024Dec 31, 2024$3.50B+0.8%
FY2023Dec 31, 2023$3.47B-8.6%
FY2022Dec 31, 2022$3.80B-3.6%
FY2021Dec 31, 2021$3.94B-1.7%
FY2020Dec 31, 2020$4.01B+9.3%
FY2019Dec 31, 2019$3.67B-15.8%
FY2018Dec 31, 2018$4.35B+224.4%
FY2017Dec 31, 2017$1.34B–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.78B+10.3%
Q1 FY2026Mar 31, 2026$3.54B+5.2%
Q4 FY2025Dec 31, 2025$3.68B+5.1%
Q3 FY2025Sep 30, 2025$3.60B+4.0%
Q2 FY2025Jun 30, 2025$3.42B-2.5%
Q1 FY2025Mar 31, 2025$3.37B-2.6%
Q4 FY2024Dec 31, 2024$3.50B+0.8%
Q3 FY2024Sep 30, 2024$3.46B-6.1%
Q2 FY2024Jun 30, 2024$3.51B-5.2%
Q1 FY2024Mar 31, 2024$3.46B-4.7%
Q4 FY2023Dec 31, 2023$3.47B-8.6%
Q3 FY2023Sep 30, 2023$3.69B-4.8%
Q2 FY2023Jun 30, 2023$3.70B-8.4%
Q1 FY2023Mar 31, 2023$3.63B-6.7%
Q4 FY2022Dec 31, 2022$3.80B-3.6%
Q3 FY2022Sep 30, 2022$3.87B-2.5%
Q2 FY2022Jun 30, 2022$4.04B+0.5%
Q1 FY2022Mar 31, 2022$3.89B-1.8%
Q4 FY2021Dec 31, 2021$3.94B-1.7%
Q3 FY2021Sep 30, 2021$3.97B-1.6%
Q2 FY2021Jun 30, 2021$4.02B-0.8%
Q1 FY2021Mar 31, 2021$3.96B-9.8%
Q4 FY2020Dec 31, 2020$4.01B+9.3%
Q3 FY2020Sep 30, 2020$4.04B+9.0%
Q2 FY2020Jun 30, 2020$4.06B-4.8%
Q1 FY2020Mar 31, 2020$4.39B+0.1%
Q4 FY2019Dec 31, 2019$3.67B-15.8%
Q3 FY2019Sep 30, 2019$3.70B-19.2%
Q2 FY2019Jun 30, 2019$4.26B-6.2%
Q1 FY2019Mar 31, 2019$4.38B–
Q4 FY2018Dec 31, 2018$4.35B+224.4%
Q3 FY2018Sep 30, 2018$4.58B–
Q2 FY2018Jun 30, 2018$4.54B–
Q1 FY2018Mar 31, 2018$0–
Q4 FY2017Dec 31, 2017$1.34B–

More Amneal Pharmaceuticals figures

See a number that looks wrong?